Navigation Links
Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned

Additional beneficial effects on cardiometabolic risk factors beyond those expected from weight loss in trials of the anti-obesity drug rimonabant may not be due to the drug itself, reports an article in the June issue of Drug and Therapeutics Bulletin (DTB).

Advertisements for rimonabant (sold under the brand name Acomplia by Sanofi-Aventis) claim that an estimated 50% of the effects on cardiometabolic risk factors are beyond those expected from weight loss alone. But DTB argues that these effects are not proven to be due to the drug itself.

Also, no published trials have compared rimonabant with either of the other anti-obesity drugs orlistat or sibutramine. Instead, rimonobants effects on weight have been assessed in four double-blind trials comparing the drug with placebo.

The article says: In three of the trial reports, the authors state that the effects of rimonabant on HDL, triglycerides and HBA1c were partly independent of weight loss. However, it is not proven that any independent effect is wholly or partially attributable to rimonabant.

The article suggests that these observed effects might be related to increased activity based on the lifestyle advice given to participants at the start of the trials.

Furthermore, it is not known whether rimonabants effects on individual risk factors translate into a reduced long-term likelihood of cardiovascular events, the article adds.

. Rimonabant has not been directly compared with other, less expensive, drug treatments for obesity. Orlistat is the drug for obesity for which there is the most evidence for efficacy and safety to date, and we have previously concluded that it is a reasonable option for obese patients where diet and exercise and/or behavioural measures alone have failed.

Rimonabant is the most expensive of the anti-obesity drugs. A years treatment with rimonabant 20mg daily costs the NHS around 720, compar
'"/>




Page: 1 2

Related medicine news :

1. Anti-obesity drugs for FDA approval
2. Canada Confronts Obesity Head-on, Anti-obesity Campaign on Fast Track
3. Lean Protein Could Be Key to Obesity Drugs
4. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Emphasis to ban Drugs ads by Doctors
7. Osteoporosis Drugs: right time to take-off
8. Drugs disrupt formation of blood vessels
9. Drugs to stop burgeon of HIV
10. Misleading Advertisements for Prescription Drugs
11. Drugs For Anthrax May Interfere With Oral Contraceptives
Post Your Comments:
(Date:5/6/2015)... May 06, 2015 Prime Pacific ... is excited to announce a new series of ... the industry’s carbon footprint while improving treatment efficacy ... Eco-Flex™, the world’s first waste hose ... game-changer for hydrotherapists,” claims the company’s president, Mr. ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part of its ... applications on the market for iOS, Android, and Windows. Joe Toohey, ... and shared with viewers how this application walks users through recipes. ... good navigator people had to know how to read a map? ... navigator. Well what if people could “GPS” their way through a ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 vcfo, a ... HR, IT and operational support to optimize business performance ... CFOs, Jack Lynch and Michael Scheaffer. Both Lynch and ... and leadership experience. , “We are delighted to ... Wood, vcfo CEO. “Leveraging their background in financial management ...
(Date:5/6/2015)... Healthcare jobs platform, JobMedic.com, has quickly ... The company connects hospitals, home-health, and other medical organizations ... industry. Likewise, job seekers are able to locate jobs ... unique traffic to the site is up more than ... posting brings targeted, interested candidates to the site through ...
(Date:5/6/2015)... The Alliance for Regenerative Medicine (ARM), ... advanced therapies community, today announced the release of ... look at sector trends and metrics from the ... is available online here and also ... here . , Using information provided by ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... seem largely visual the preening, the coy eye contact ... voice may be a means of demonstrating attraction, says Susan ... Pa., in a study, "Vocal and Physiological Changes in Response ... in the fall by the Journal of Nonverbal Behavior ...
... ... play weather, the National Recreation and Park Association (NRPA) is reminding Americans to take the ... To assist, NRPA has published The Dirty Dozen, a comprehensive brochure and playground-safety resource ... ...
... ... Patient Satisfaction Conference June 4th 2010. Expert speakers will discuss improving communications between caregivers, ... , ... 2010 -- Scan Am Company of Algonquin, Illinois, will be hosting a Patient Safety ...
... and when they were readmitted , THURSDAY, May 20 ... disease who decide to discharge themselves before their doctors ... and when they are readmitted. , The finding, set ... for Pharmacoeconomics and Outcomes Research meeting in Atlanta, comes ...
... Gastroesophageal reflux (GER), defined as passage of gastric contents ... in healthy infants, children and adults. When GER causes ... gastroesophageal reflux disease (GERD). During infancy, GER is common ... non-specific symptoms as irritability and cough. Association of non-specific ...
... a study published today in the journal Addiction , ... effective among people with severe mental illnesses as it is ... offering such treatments does not appear to cause deterioration in ... severe mental illnesses (SMI) such as schizophrenia have some of ...
Cached Medicine News:Health News:The sound of seduction 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 3Health News:Patient Safety and Satisfaction are Key Issues at Scan Am Company June Conference 2Health News:When Heart Patients Discharge Themselves, Hospital Bills Increase 2Health News:Disagreement on symptom-reflux association analysis parameters in infants 2Health News:Smoking cessation treatments work and are safe for people with severe mental illness 2
(Date:5/6/2015)... PARIS , May 6, 2015 ... the development and manufacture of filtration products, mainly for ... ZenPure designs custom filters manufactured in a state-of-the-art plant ... are marketed and sold across the globe and will ... Plastics business. This acquisition is fully in ...
(Date:5/6/2015)... , May 6, 2015  Membership in Medicare Supplement ... a Healthcare Business Strategy report released by Mark ... as Medigap or Med Supp plans, covered approximately ... a 5.2% increase from 2013. Between 2013 and ... 551,135 covered lives.  Though UnitedHealth was the segment ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/7qn2gf/global_insulin ... "Global Insulin Patch Market Opportunity Analysis" report ... like ultrasound and iontophoresis are being used for ... the type of technique, their prices may vary ... patients. In long-term, it would be considered as ...
Breaking Medicine Technology:Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Global Insulin Patch Market Opportunity Analysis 2015 2
... First Effective Drug for Rare Genetic Disorder in,Children--, ... drug to achieve normal levels of blood sugar ... levels. If this approach,succeeds in humans, it could ... a rare but potentially devastating genetic,disease in which ...
... Pathwork Diagnostics, Gene Expression Test Is the First to Receive FDA, ... ... U.S. Cancer Cases Annually, SUNNYVALE, Calif., July 31 Pathwork ... U.S. Food and Drug Administration (FDA) has cleared its Pathwork(R),Tissue of ...
Cached Medicine Technology:Treatment Corrects Severe Insulin Imbalance in Animal Studies 2Treatment Corrects Severe Insulin Imbalance in Animal Studies 3FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 2FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 3FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 4